Technologies

JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva® in Patients with Relapsed or Refractory Mantle Cell Lymphoma

  • by

​ SHANGHAI, Jan. 4, 2024 /PRNewswire/ — JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products Administration (NMPA) of China accepted… Read More »JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva® in Patients with Relapsed or Refractory Mantle Cell Lymphoma

AIMA, the global leader in e-mobility industry, participates in the CES Show for the first time, unveiling its global strategic blueprint

  • by

​ LAS VEGAS, Jan. 4, 2024 /PRNewswire/ — From January 9th to 12th, 2024, the world’s premier event for consumer electronics technology—the Consumer Electronics Show (CES)—will take place in Las Vegas. AIMA, one of the… Read More »AIMA, the global leader in e-mobility industry, participates in the CES Show for the first time, unveiling its global strategic blueprint